Beta Bionics, Inc. (BBNX) stock
BBNXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 11/304% below fair value
$14.72−0.49 (-3.22%)
Close on Nov 17, 2026Market cap $800.28MP/E –Yield –
Beta Bionics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Beta Bionics's price to book ratio was 3.1× on Nov 11, 2026, against 4.7× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.1× | −1.4 |
| 2025 | Dec 31, 2025 | 4.5× | – |
See a number that looks wrong?